Keyphrases
COVID-19
81%
Coronavirus Disease (COVID)
79%
Confidence Interval
48%
United States
34%
Retrospective Cohort Study
33%
Odds Ratio
28%
Hospitalization
28%
Hazard Ratio
26%
Older Patients
25%
Comparative Effectiveness
23%
Muscle-invasive Bladder Cancer
20%
Nursing Homes
20%
Direct Oral Anticoagulants
19%
Radical Cystectomy
17%
Older Adults
17%
Long COVID
16%
Dementia
16%
Comorbidity
16%
Nursing Home Residents
16%
Remdesivir
15%
Medicare
13%
Comorbidity Scores
13%
Medicare Beneficiaries
13%
COVID-19 Diagnosis
12%
SARS-CoV-2 Infection
12%
Bladder Cancer
12%
Atrial Fibrillation
11%
Warfarin
11%
Type 2 Diabetic Patients
11%
Risk Factors
11%
30-day Mortality
11%
Survival Outcomes
10%
Adjusted Hazard Ratio
10%
Type 2 Diabetes Mellitus (T2DM)
9%
Elixhauser Comorbidity Index
8%
Length of Stay
8%
Race-ethnicity
8%
Drug Interactions
8%
Hospitalization Risk
8%
Long-term Care Homes
8%
Hospitalized Adults
8%
Relative Risk
8%
Adult Cancer
8%
Enhanced Recovery
8%
Severe COVID-19
8%
In-hospital Mortality
8%
Risk Index
7%
Risk Adjustment
7%
Combined Modality Therapy
7%
Benzodiazepine Dependence
7%
Medicine and Dentistry
COVID-19
100%
Medicare
44%
Retrospective Cohort Study
30%
Severe Acute Respiratory Syndrome Coronavirus 2
28%
Odds Ratio
27%
Health Care Cost
26%
Hazard Ratio
25%
Infection
25%
Muscle Invasive Bladder Cancer
24%
Cystectomy
23%
Drug Therapy
22%
Malignant Neoplasm
20%
Postcovid Syndrome
19%
Disease
15%
Surgery
14%
Sequela
13%
Bladder Cancer
13%
Quality Improvement
13%
Cohort Analysis
13%
Maturity Onset Diabetes of the Young
12%
Nursing Home
11%
Patient with Type 2 Diabetes
11%
Logistic Regression Analysis
11%
Colectomy
11%
Electronic Health Record
11%
Cross Sectional Study
10%
Diagnosis-Related Group
9%
Surgeon
8%
Emergency Department
8%
Proportional Hazards Model
8%
Postoperative Complication
8%
Hypoglycemia
7%
Gestational Age
7%
Systematic Review
7%
Artificial Respiration
7%
Diabetes
7%
Chronic Disease
7%
Charlson Comorbidity Index
7%
Glucagon-Like Peptide-1 Agonist
7%
Anticoagulation
7%
Cholecystectomy
6%
Health System
6%
Psychiatric Diagnosis
6%
Elderly Patient
6%
Dipeptidyl Peptidase-4 Inhibitor
6%
Immunosuppressive Drug
6%
COVID-19 Diagnosis
6%
Elixhauser Comorbidity Index
6%
Outpatient
6%
Prevalence
6%